KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $31.1 million.

  • Idexx Laboratories' Capital Expenditures rose 1076.93% to $31.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.5 million, marking a year-over-year increase of 22.06%. This contributed to the annual value of $120.9 million for FY2024, which is 951.05% down from last year.
  • Per Idexx Laboratories' latest filing, its Capital Expenditures stood at $31.1 million for Q3 2025, which was up 1076.93% from $34.1 million recorded in Q2 2025.
  • Idexx Laboratories' Capital Expenditures' 5-year high stood at $49.2 million during Q4 2022, with a 5-year trough of $20.2 million in Q1 2021.
  • Moreover, its 5-year median value for Capital Expenditures was $31.8 million (2021), whereas its average is $32.5 million.
  • Examining YoY changes over the last 5 years, Idexx Laboratories' Capital Expenditures showed a top increase of 13434.15% in 2021 and a maximum decrease of 5885.27% in 2021.
  • Quarter analysis of 5 years shows Idexx Laboratories' Capital Expenditures stood at $31.8 million in 2021, then soared by 54.87% to $49.2 million in 2022, then tumbled by 33.87% to $32.6 million in 2023, then dropped by 10.14% to $29.3 million in 2024, then grew by 6.35% to $31.1 million in 2025.
  • Its last three reported values are $31.1 million in Q3 2025, $34.1 million for Q2 2025, and $30.0 million during Q1 2025.